| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |